Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients meeting ACC/AHA criteria for paroxysmal atrial fibrillation (episodes typically last no more than 7 days and are self-terminating)~* Eligible for pulmonary vein isolation~* Able to tolerate antiarrhythmic medication~Exclusion Criteria:~* Age \<18~* Persistent or permanent atrial fibrillation (episodes last \>7 days and require cardioversion)~* Antiarrhythmic treatment for indication other than atrial fibrillation~* Contraindication or intolerance to all antiarrhythmic medications~* Primary physician unwilling to withhold antiarrhythmic drugs for duration of the study~* Failure to obtain informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- AAD:YES (Type: OTHER): Subjects receive membrane-active anti-arrhythmic medication after ablation. See intervention list below.
- AAD:NO (Type: OTHER): Subjects do not receive membrane-active anti-arrhythmic medications after ablation.

Based on this trial design, predict the completion outcome and termination type (if applicable).